カテゴリー： 世界, 医療/バイオ, LP Information

世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年

【英語タイトル】Global Tamsulosin Hydrochloride Sustained Release Capsules Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC08733）・商品コード：LP23DC08733
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のタムスロシン塩酸塩徐放性カプセル市場」は、過去の販売実績から2022年の世界のタムスロシン塩酸塩徐放性カプセルの総販売量を検討し、2023年から2029年の予測されるタムスロシン塩酸塩徐放性カプセルの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のタムスロシン塩酸塩徐放性カプセルの市場規模を掲載し、XXX百万米ドル規模の世界のタムスロシン塩酸塩徐放性カプセル市場の詳細な分析を提供します。本インサイトレポートは、世界のタムスロシン塩酸塩徐放性カプセル業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のタムスロシン塩酸塩徐放性カプセル市場における各社の独自のポジションをより深く理解するために、タムスロシン塩酸塩徐放性カプセル製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のタムスロシン塩酸塩徐放性カプセル市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。タムスロシン塩酸塩徐放性カプセルの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。タムスロシン塩酸塩徐放性カプセルの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。タムスロシン塩酸塩徐放性カプセルのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

タムスロシン塩酸塩徐放性カプセルの世界主要メーカーとしては、Astellas Pharma Inc.、 Shenzhen Wanhe Pharmaceutical Co., Ltd.、 Zhejiang Conba Pharmaceutical Co., Ltd.、 Guangdong Huanan Pharmaceutical Group Co., Ltd.、 Hailisheng Group Co., Ltd.、 Shanghai Anbison Pharmaceutical Technology Co., Ltd.、 Jiangxi Shanxiang Pharmaceutical Co., Ltd.、 Jiangsu Hengrui Pharmaceuticals Co.,ltd.、 Sandoz Canada、 Sanofi、 Murli Krishna Pharma、 DM Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のタムスロシン塩酸塩徐放性カプセル市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではタムスロシン塩酸塩徐放性カプセル市場をセグメンテーションし、種類別 (先発医薬品、ジェネリック医薬品)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：先発医薬品、ジェネリック医薬品

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のタムスロシン塩酸塩徐放性カプセル市場の10年間の市場状況・展望は？
・世界および地域別に見たタムスロシン塩酸塩徐放性カプセル市場成長の要因は何か？
・タムスロシン塩酸塩徐放性カプセルの市場機会はエンドマーケットの規模によってどのように変化するのか？
・タムスロシン塩酸塩徐放性カプセルのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：タムスロシン塩酸塩徐放性カプセルの年間販売量2018-2029、地域別現状・将来分析
・タムスロシン塩酸塩徐放性カプセルの種類別セグメント：先発医薬品、ジェネリック医薬品
・タムスロシン塩酸塩徐放性カプセルの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・タムスロシン塩酸塩徐放性カプセルの用途別セグメント：病院、診療所、その他
・タムスロシン塩酸塩徐放性カプセルの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のタムスロシン塩酸塩徐放性カプセル市場
・企業別のグローバルタムスロシン塩酸塩徐放性カプセル市場データ：2018-2023年の年間販売量、市場シェア
・企業別のタムスロシン塩酸塩徐放性カプセルの年間売上：2018-2023年の売上、市場シェア
・企業別のタムスロシン塩酸塩徐放性カプセル販売価格
・主要企業のタムスロシン塩酸塩徐放性カプセル生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

タムスロシン塩酸塩徐放性カプセルの地域別レビュー
・地域別のタムスロシン塩酸塩徐放性カプセル市場規模2018-2023：年間販売量、売上
・主要国別のタムスロシン塩酸塩徐放性カプセル市場規模2018-2023：年間販売量、売上
・南北アメリカのタムスロシン塩酸塩徐放性カプセル販売の成長
・アジア太平洋のタムスロシン塩酸塩徐放性カプセル販売の成長
・ヨーロッパのタムスロシン塩酸塩徐放性カプセル販売の成長
・中東・アフリカのタムスロシン塩酸塩徐放性カプセル販売の成長

南北アメリカ市場
・南北アメリカの国別のタムスロシン塩酸塩徐放性カプセル販売量、売上（2018-2023）
・南北アメリカのタムスロシン塩酸塩徐放性カプセルの種類別販売量
・南北アメリカのタムスロシン塩酸塩徐放性カプセルの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のタムスロシン塩酸塩徐放性カプセル販売量、売上（2018-2023）
・アジア太平洋のタムスロシン塩酸塩徐放性カプセルの種類別販売量
・アジア太平洋のタムスロシン塩酸塩徐放性カプセルの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のタムスロシン塩酸塩徐放性カプセル販売量、売上（2018-2023）
・ヨーロッパのタムスロシン塩酸塩徐放性カプセルの種類別販売量
・ヨーロッパのタムスロシン塩酸塩徐放性カプセルの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のタムスロシン塩酸塩徐放性カプセル販売量、売上（2018-2023）
・中東・アフリカのタムスロシン塩酸塩徐放性カプセルの種類別販売量
・中東・アフリカのタムスロシン塩酸塩徐放性カプセルの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・タムスロシン塩酸塩徐放性カプセルの製造コスト構造分析
・タムスロシン塩酸塩徐放性カプセルの製造プロセス分析
・タムスロシン塩酸塩徐放性カプセルの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・タムスロシン塩酸塩徐放性カプセルの主要なグローバル販売業者
・タムスロシン塩酸塩徐放性カプセルの主要なグローバル顧客

地域別のタムスロシン塩酸塩徐放性カプセル市場予測レビュー
・地域別のタムスロシン塩酸塩徐放性カプセル市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・タムスロシン塩酸塩徐放性カプセルの種類別市場規模予測
・タムスロシン塩酸塩徐放性カプセルの用途別市場規模予測

主要企業分析
Astellas Pharma Inc.、 Shenzhen Wanhe Pharmaceutical Co., Ltd.、 Zhejiang Conba Pharmaceutical Co., Ltd.、 Guangdong Huanan Pharmaceutical Group Co., Ltd.、 Hailisheng Group Co., Ltd.、 Shanghai Anbison Pharmaceutical Technology Co., Ltd.、 Jiangxi Shanxiang Pharmaceutical Co., Ltd.、 Jiangsu Hengrui Pharmaceuticals Co.,ltd.、 Sandoz Canada、 Sanofi、 Murli Krishna Pharma、 DM Pharma
・企業情報
・タムスロシン塩酸塩徐放性カプセル製品
・タムスロシン塩酸塩徐放性カプセル販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Tamsulosin Hydrochloride Sustained Release Capsules market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tamsulosin Hydrochloride Sustained Release Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tamsulosin Hydrochloride Sustained Release Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tamsulosin Hydrochloride Sustained Release Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tamsulosin Hydrochloride Sustained Release Capsules players cover Astellas Pharma Inc., Shenzhen Wanhe Pharmaceutical Co., Ltd., Zhejiang Conba Pharmaceutical Co., Ltd., Guangdong Huanan Pharmaceutical Group Co., Ltd., Hailisheng Group Co., Ltd., Shanghai Anbison Pharmaceutical Technology Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd. and Sandoz Canada, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Tamsulosin Hydrochloride Sustained Release Capsules Industry Forecast” looks at past sales and reviews total world Tamsulosin Hydrochloride Sustained Release Capsules sales in 2022, providing a comprehensive analysis by region and market sector of projected Tamsulosin Hydrochloride Sustained Release Capsules sales for 2023 through 2029. With Tamsulosin Hydrochloride Sustained Release Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tamsulosin Hydrochloride Sustained Release Capsules industry.
This Insight Report provides a comprehensive analysis of the global Tamsulosin Hydrochloride Sustained Release Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tamsulosin Hydrochloride Sustained Release Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tamsulosin Hydrochloride Sustained Release Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tamsulosin Hydrochloride Sustained Release Capsules and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tamsulosin Hydrochloride Sustained Release Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Tamsulosin Hydrochloride Sustained Release Capsules market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Original Drug
Generic Drug
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Astellas Pharma Inc.
Shenzhen Wanhe Pharmaceutical Co., Ltd.
Zhejiang Conba Pharmaceutical Co., Ltd.
Guangdong Huanan Pharmaceutical Group Co., Ltd.
Hailisheng Group Co., Ltd.
Shanghai Anbison Pharmaceutical Technology Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
Sandoz Canada
Sanofi
Murli Krishna Pharma
DM Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tamsulosin Hydrochloride Sustained Release Capsules market?
What factors are driving Tamsulosin Hydrochloride Sustained Release Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tamsulosin Hydrochloride Sustained Release Capsules market opportunities vary by end market size?
How does Tamsulosin Hydrochloride Sustained Release Capsules break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tamsulosin Hydrochloride Sustained Release Capsules by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tamsulosin Hydrochloride Sustained Release Capsules by Country/Region, 2018, 2022 & 2029
2.2 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type
2.3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
2.3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Type (2018-2023)
2.4 Tamsulosin Hydrochloride Sustained Release Capsules Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application
2.5.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Market Share by Application (2018-2023)
2.5.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Application (2018-2023)
3 Global Tamsulosin Hydrochloride Sustained Release Capsules by Company
3.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Breakdown Data by Company
3.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales by Company (2018-2023)
3.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Company (2018-2023)
3.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Revenue by Company (2018-2023)
3.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Company (2018-2023)
3.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Company (2018-2023)
3.3 Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Company
3.4 Key Manufacturers Tamsulosin Hydrochloride Sustained Release Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tamsulosin Hydrochloride Sustained Release Capsules Product Location Distribution
3.4.2 Players Tamsulosin Hydrochloride Sustained Release Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tamsulosin Hydrochloride Sustained Release Capsules by Geographic Region
4.1 World Historic Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Geographic Region (2018-2023)
4.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tamsulosin Hydrochloride Sustained Release Capsules Market Size by Country/Region (2018-2023)
4.2.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Growth
4.4 APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Growth
4.5 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Growth
4.6 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Growth
5 Americas
5.1 Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country
5.1.1 Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023)
5.1.2 Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023)
5.2 Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type
5.3 Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region
6.1.1 APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2018-2023)
6.1.2 APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2018-2023)
6.2 APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type
6.3 APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules by Country
7.1.1 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023)
7.1.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023)
7.2 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type
7.3 Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules by Country
8.1.1 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023)
8.2 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type
8.3 Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tamsulosin Hydrochloride Sustained Release Capsules
10.3 Manufacturing Process Analysis of Tamsulosin Hydrochloride Sustained Release Capsules
10.4 Industry Chain Structure of Tamsulosin Hydrochloride Sustained Release Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tamsulosin Hydrochloride Sustained Release Capsules Distributors
11.3 Tamsulosin Hydrochloride Sustained Release Capsules Customer
12 World Forecast Review for Tamsulosin Hydrochloride Sustained Release Capsules by Geographic Region
12.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Market Size Forecast by Region
12.1.1 Global Tamsulosin Hydrochloride Sustained Release Capsules Forecast by Region (2024-2029)
12.1.2 Global Tamsulosin Hydrochloride Sustained Release Capsules Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tamsulosin Hydrochloride Sustained Release Capsules Forecast by Type
12.7 Global Tamsulosin Hydrochloride Sustained Release Capsules Forecast by Application
13 Key Players Analysis
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.1.3 Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Shenzhen Wanhe Pharmaceutical Co., Ltd.
13.2.1 Shenzhen Wanhe Pharmaceutical Co., Ltd. Company Information
13.2.2 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.2.3 Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shenzhen Wanhe Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Shenzhen Wanhe Pharmaceutical Co., Ltd. Latest Developments
13.3 Zhejiang Conba Pharmaceutical Co., Ltd.
13.3.1 Zhejiang Conba Pharmaceutical Co., Ltd. Company Information
13.3.2 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.3.3 Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zhejiang Conba Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Zhejiang Conba Pharmaceutical Co., Ltd. Latest Developments
13.4 Guangdong Huanan Pharmaceutical Group Co., Ltd.
13.4.1 Guangdong Huanan Pharmaceutical Group Co., Ltd. Company Information
13.4.2 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.4.3 Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Guangdong Huanan Pharmaceutical Group Co., Ltd. Main Business Overview
13.4.5 Guangdong Huanan Pharmaceutical Group Co., Ltd. Latest Developments
13.5 Hailisheng Group Co., Ltd.
13.5.1 Hailisheng Group Co., Ltd. Company Information
13.5.2 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.5.3 Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hailisheng Group Co., Ltd. Main Business Overview
13.5.5 Hailisheng Group Co., Ltd. Latest Developments
13.6 Shanghai Anbison Pharmaceutical Technology Co., Ltd.
13.6.1 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Company Information
13.6.2 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.6.3 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Main Business Overview
13.6.5 Shanghai Anbison Pharmaceutical Technology Co., Ltd. Latest Developments
13.7 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
13.7.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Company Information
13.7.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.7.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Latest Developments
13.8 Jiangsu Hengrui Pharmaceuticals Co.,ltd.
13.8.1 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
13.8.2 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.8.3 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business Overview
13.8.5 Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
13.9 Sandoz Canada
13.9.1 Sandoz Canada Company Information
13.9.2 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.9.3 Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sandoz Canada Main Business Overview
13.9.5 Sandoz Canada Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.10.3 Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Murli Krishna Pharma
13.11.1 Murli Krishna Pharma Company Information
13.11.2 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.11.3 Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Murli Krishna Pharma Main Business Overview
13.11.5 Murli Krishna Pharma Latest Developments
13.12 DM Pharma
13.12.1 DM Pharma Company Information
13.12.2 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
13.12.3 DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 DM Pharma Main Business Overview
13.12.5 DM Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tamsulosin Hydrochloride Sustained Release Capsules Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023) & (K Boxes)
Table 6. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
Table 7. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Type (2018-2023) & ($ million)
Table 8. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2018-2023)
Table 9. Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Type (2018-2023) & (US$/Box)
Table 10. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023) & (K Boxes)
Table 11. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2023)
Table 12. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Application (2018-2023)
Table 13. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application (2018-2023)
Table 14. Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Application (2018-2023) & (US$/Box)
Table 15. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Company (2018-2023) & (K Boxes)
Table 16. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Company (2018-2023)
Table 17. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Company (2018-2023)
Table 19. Global Tamsulosin Hydrochloride Sustained Release Capsules Sale Price by Company (2018-2023) & (US$/Box)
Table 20. Key Manufacturers Tamsulosin Hydrochloride Sustained Release Capsules Producing Area Distribution and Sales Area
Table 21. Players Tamsulosin Hydrochloride Sustained Release Capsules Products Offered
Table 22. Tamsulosin Hydrochloride Sustained Release Capsules Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Geographic Region (2018-2023) & (K Boxes)
Table 26. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share Geographic Region (2018-2023)
Table 27. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country/Region (2018-2023) & (K Boxes)
Table 30. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country/Region (2018-2023)
Table 31. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023) & (K Boxes)
Table 34. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2023)
Table 35. Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2023)
Table 37. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023) & (K Boxes)
Table 38. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023) & (K Boxes)
Table 39. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2018-2023) & (K Boxes)
Table 40. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Region (2018-2023)
Table 41. APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Region (2018-2023)
Table 43. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023) & (K Boxes)
Table 44. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023) & (K Boxes)
Table 45. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023) & (K Boxes)
Table 46. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2023)
Table 47. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2023)
Table 49. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023) & (K Boxes)
Table 50. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023) & (K Boxes)
Table 51. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Country (2018-2023) & (K Boxes)
Table 52. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Type (2018-2023) & (K Boxes)
Table 56. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales by Application (2018-2023) & (K Boxes)
Table 57. Key Market Drivers & Growth Opportunities of Tamsulosin Hydrochloride Sustained Release Capsules
Table 58. Key Market Challenges & Risks of Tamsulosin Hydrochloride Sustained Release Capsules
Table 59. Key Industry Trends of Tamsulosin Hydrochloride Sustained Release Capsules
Table 60. Tamsulosin Hydrochloride Sustained Release Capsules Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Tamsulosin Hydrochloride Sustained Release Capsules Distributors List
Table 63. Tamsulosin Hydrochloride Sustained Release Capsules Customer List
Table 64. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Region (2024-2029) & (K Boxes)
Table 65. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Country (2024-2029) & (K Boxes)
Table 67. Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Region (2024-2029) & (K Boxes)
Table 69. APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Country (2024-2029) & (K Boxes)
Table 71. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Country (2024-2029) & (K Boxes)
Table 73. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Type (2024-2029) & (K Boxes)
Table 75. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Forecast by Application (2024-2029) & (K Boxes)
Table 77. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Astellas Pharma Inc. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 80. Astellas Pharma Inc. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 81. Astellas Pharma Inc. Main Business
Table 82. Astellas Pharma Inc. Latest Developments
Table 83. Shenzhen Wanhe Pharmaceutical Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 84. Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 85. Shenzhen Wanhe Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 86. Shenzhen Wanhe Pharmaceutical Co., Ltd. Main Business
Table 87. Shenzhen Wanhe Pharmaceutical Co., Ltd. Latest Developments
Table 88. Zhejiang Conba Pharmaceutical Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 89. Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 90. Zhejiang Conba Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 91. Zhejiang Conba Pharmaceutical Co., Ltd. Main Business
Table 92. Zhejiang Conba Pharmaceutical Co., Ltd. Latest Developments
Table 93. Guangdong Huanan Pharmaceutical Group Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 95. Guangdong Huanan Pharmaceutical Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 96. Guangdong Huanan Pharmaceutical Group Co., Ltd. Main Business
Table 97. Guangdong Huanan Pharmaceutical Group Co., Ltd. Latest Developments
Table 98. Hailisheng Group Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 100. Hailisheng Group Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 101. Hailisheng Group Co., Ltd. Main Business
Table 102. Hailisheng Group Co., Ltd. Latest Developments
Table 103. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 105. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 106. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Main Business
Table 107. Shanghai Anbison Pharmaceutical Technology Co., Ltd. Latest Developments
Table 108. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 109. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 110. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 111. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Main Business
Table 112. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Latest Developments
Table 113. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 115. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 116. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Main Business
Table 117. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Latest Developments
Table 118. Sandoz Canada Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 119. Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 120. Sandoz Canada Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 121. Sandoz Canada Main Business
Table 122. Sandoz Canada Latest Developments
Table 123. Sanofi Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 125. Sanofi Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. Murli Krishna Pharma Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 129. Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 130. Murli Krishna Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 131. Murli Krishna Pharma Main Business
Table 132. Murli Krishna Pharma Latest Developments
Table 133. DM Pharma Basic Information, Tamsulosin Hydrochloride Sustained Release Capsules Manufacturing Base, Sales Area and Its Competitors
Table 134. DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Product Portfolios and Specifications
Table 135. DM Pharma Tamsulosin Hydrochloride Sustained Release Capsules Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 136. DM Pharma Main Business
Table 137. DM Pharma Latest Developments
List of Figures
Figure 1. Picture of Tamsulosin Hydrochloride Sustained Release Capsules
Figure 2. Tamsulosin Hydrochloride Sustained Release Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Growth Rate 2018-2029 (K Boxes)
Figure 7. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tamsulosin Hydrochloride Sustained Release Capsules Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type in 2022
Figure 12. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Type (2018-2023)
Figure 13. Tamsulosin Hydrochloride Sustained Release Capsules Consumed in Hospital
Figure 14. Global Tamsulosin Hydrochloride Sustained Release Capsules Market: Hospital (2018-2023) & (K Boxes)
Figure 15. Tamsulosin Hydrochloride Sustained Release Capsules Consumed in Clinic
Figure 16. Global Tamsulosin Hydrochloride Sustained Release Capsules Market: Clinic (2018-2023) & (K Boxes)
Figure 17. Tamsulosin Hydrochloride Sustained Release Capsules Consumed in Other
Figure 18. Global Tamsulosin Hydrochloride Sustained Release Capsules Market: Other (2018-2023) & (K Boxes)
Figure 19. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2022)
Figure 20. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Application in 2022
Figure 21. Tamsulosin Hydrochloride Sustained Release Capsules Sales Market by Company in 2022 (K Boxes)
Figure 22. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Company in 2022
Figure 23. Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Company in 2022
Figure 25. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2023 (K Boxes)
Figure 28. Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2023 ($ Millions)
Figure 29. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2023 (K Boxes)
Figure 30. APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2023 ($ Millions)
Figure 31. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2023 (K Boxes)
Figure 32. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales 2018-2023 (K Boxes)
Figure 34. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue 2018-2023 ($ Millions)
Figure 35. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country in 2022
Figure 36. Americas Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country in 2022
Figure 37. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
Figure 38. Americas Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2023)
Figure 39. United States Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Region in 2022
Figure 44. APAC Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Regions in 2022
Figure 45. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
Figure 46. APAC Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2023)
Figure 47. China Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country in 2022
Figure 55. Europe Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country in 2022
Figure 56. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
Figure 57. Europe Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2023)
Figure 58. Germany Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share by Application (2018-2023)
Figure 67. Egypt Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Tamsulosin Hydrochloride Sustained Release Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Tamsulosin Hydrochloride Sustained Release Capsules in 2022
Figure 73. Manufacturing Process Analysis of Tamsulosin Hydrochloride Sustained Release Capsules
Figure 74. Industry Chain Structure of Tamsulosin Hydrochloride Sustained Release Capsules
Figure 75. Channels of Distribution
Figure 76. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Forecast by Region (2024-2029)
Figure 77. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Tamsulosin Hydrochloride Sustained Release Capsules Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Tamsulosin Hydrochloride Sustained Release Capsules Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年] (コード：LP23DC08733)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の塩酸オキシコドン徐放性薬剤市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性錠剤市場予測 2023年-2029年
  • 世界のホスネツピタント＆塩酸パロノセトロンカプセル市場予測 2023年-2029年
  • 世界のニロチニブカプセル市場予測 2023年-2029年
  • 世界の医薬品用トラゾドン塩酸塩市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆